Skip to nav Skip to content

At Moffitt Cancer Center, we believe clinical trials are an essential part of the cancer care continuum. Every day, we improve patient outcomes and quality of life by matching our patients with promising new treatment options, including those available through the immunotherapy clinical trials overseen by our renowned Blood and Marrow Transplant and Cellular Immunotherapy Program. Working diligently in collaboration with cancer centers across the nation, we have achieved many significant research breakthroughs, and we continue to make great progress in our fight against cancer.

Immunotherapy is a very active area of research at Moffitt, and our outstanding scientists and clinicians are continually exploring new ways to design and implement these advanced treatments. While several drugs and cellular immunotherapies are already approved for treating cancer, hundreds more are available to clinical trial participants. For some cancer patients, joining a clinical trial is the best course of action.

It is now well known that the immune system that helps protect a person from external illnesses, such as infections, is also capable of killing cancer cells. Cellular immunotherapy treatments are a relatively new type of cancer treatment that uses immune cells that are modified to more effectively attack cancer cells.

At Moffitt Cancer Center, we offer clinical trials that allow access to some of the cutting-edge cellular immunotherapy treatments that are not available at many other hospitals. Current trials include cellular therapy treatments for a variety of cancers including hematologic malignancies (leukemia, lymphoma, myeloma) and solid tumor cancers ( head and neck, ovarian, lung, gastrointestinal, sarcoma, etc.) and more trials being opened over time. 

Helping our shared patients explore their options

Many cancer patients are unaware that they may have opportunities to benefit from clinical trials. At Moffitt, we are privileged to collaborate with referring physicians, and we are committed to helping you educate your patients about the latest developments in immunotherapy so that they can make the best possible treatment decisions. For information about our research studies that are accepting new patients, call 1-813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.

Medically reviewed by Hany Elmariah, MD, MS

If you would like to refer a patient to our Blood and Marrow Transplant and Cellular Immunotherapy Program, complete our online form or contact a physician liaison for assistance. While under the care of the multispecialty team at Moffitt, your patient will receive outstanding clinical services and support, and you will receive timely and informative updates on his or her progress.